(c) 2024 PillSync.com

apremilast kit apremilast 30 mg tablet film coated

1 INDICATIONS AND USAGE Apremilast, an inhibitor of phosphodiesterase 4 (PDE4), is indicated for the treatment of: Adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. ( 1.2 ) 1.2 Psoriasis Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

amneal pharmaceuticals ny llc


3 years ago OVAL PINK C14 apremilast kit apremilast 30 mg tablet film coated

OVAL PINK C14

16 HOW SUPPLIED/STORAGE AND HANDLING Apremilast Tablets, 10 mg are supplied as pink colored, oval shaped, film-coated tablets, debossed with “C12” on one side and plain on other side. Apremilast Tablets, 20 mg are supplied as brown colored, oval shaped, film-coated tablet, debossed with "C13” on one side and plain on other side. Apremilast Tablets, 30 mg are supplied as beige colored, oval shaped, film-coated tablets, debossed with “C14" on one side and plain on other side. Tablets are supplied in the following strengths and package configurations: Package Configuration Tablet Strength NDC number Bottles of 60 30 mg NDC 60219-1410-6 Two week starter pack 13-tablet blister titration pack containing: (4) 10-mg, (4) 20-mg, and (5) 30-mg tablets with an additional (14) 30-mg tablets NDC 60219-1744-7 Storage and Handling Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].


More pills like OVAL C14

Related Pills

lamotrigine tablet

cipla usa inc.

darunavir 800 mg

amneal pharmaceuticals ny llc












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site